pindolol and Diseases, Peripheral Vascular studies

Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.

Research Excerpts

Excerpt	Relevance	Reference
"For this update, the Cochrane Peripheral Vascular Diseases Group Trials Search Co-ordinator searched the Specialised Register (last searched March 2013) and the Cochrane Central Register of Controlled Trials (CENTRAL, The Cochrane Library, 2013, Issue 2)."	2.49	Beta blockers for peripheral arterial disease. ( Da Silva, A; Mendonca, DA; Paravastu, SC, 2013)
"The Cochrane Peripheral Vascular Diseases (PVD) Group searched for publications describing randomised controlled trials (RCTs) of beta blockers in PAD in their Trials Register (last searched 6 May 2008) and the Cochrane Central Register of Controlled Trials (CENTRAL) (last searched The Cochrane Library 2008, Issue 2)."	2.44	Beta blockers for peripheral arterial disease. ( Da Silva, A; Mendonca, D; Paravastu, SC, 2008)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Article	Year
Beta blockers for peripheral arterial disease. The Cochrane database of systematic reviews, 2013, Sep-11, Issue:9 Topics: Adrenergic beta-Antagonists; Atenolol; Humans; Intermittent Claudication; Metoprolol; Peripheral Vas	2013
Beta blockers for peripheral arterial disease. The Cochrane database of systematic reviews, 2008, Oct-08, Issue:4 Topics: Adrenergic beta-Antagonists; Atenolol; Humans; Intermittent Claudication; Metoprolol; Peripheral Vas	2008

pindolol and Diseases, Peripheral Vascular

Research Excerpts

Research

Studies (2)

Authors

Reviews